Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

Colin McGuckin; Nico Forraz; Clément Milet; Mathieu Lacroix; Yordan Sbirkov; Victoria Sarafian; Caroline Ebel; Anita Spindler; Véronique Koerper; Jean-Marc Balloul; Philippe Erbs

doi:10.3390/cancers17223705

November 19, 2025CancersOpen Access

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

View Full Paper

Ask AI

Bookmark

Share

Key Points

Oncolytic viral delivery improves effectiveness in treating colorectal cancer metastasis, enhancing therapeutic insight.
Key evidence includes the application of advanced 3D bioprinting in modeling tumor environments and testing drug efficacy.
The approach involves 3D bioprinting used to replicate hepatic metastasis for testing chemotherapeutic agents.
This highlights the potential for better preclinical models to improve drug delivery in cancer therapy.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis assesses 3D bioprinting's role in oncolytic viral delivery for colorectal cancer, suggesting enhanced preclinical screening outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McGuckin et al. (2025) studied this question.

synapsesocial.com/papers/6924fed8c0ce034ddc3512f6 https://doi.org/10.3390/cancers17223705

View Full Paper

Ask AI

Bookmark

Share

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading